Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
03/19

DJ Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. $(EW)$ slipped 1.97% to $82.61 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.36% to 6,624.70 and Dow Jones Industrial Average falling 1.63% to 46,225.15.

The stock's fall snapped a two-day winning streak.

Edwards Lifesciences Corp. closed 6.01% below its 52-week high of $87.89, which the company achieved on December 5th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Abbott Laboratories $(ABT)$ fell 2.01% to $108.49, Medtronic PLC $(MDT)$ fell 1.39% to $87.21, and Stryker Corp. $(SYK)$ fell 0.95% to $345.81.

Trading volume (3.4 M) remained 1.2 million below its 50-day average volume of 4.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 18, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 18, 2026 16:51 ET (20:51 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10